Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16534785rdf:typepubmed:Citationlld:pubmed
pubmed-article:16534785lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0004610lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0042313lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C1518527lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:16534785lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:16534785pubmed:issue8lld:pubmed
pubmed-article:16534785pubmed:dateCreated2006-4-12lld:pubmed
pubmed-article:16534785pubmed:abstractTextThe clinical significance of infections caused by vancomycin-tolerant (Vt) gram-positive organisms in patients with cancer remains unclear.lld:pubmed
pubmed-article:16534785pubmed:languageenglld:pubmed
pubmed-article:16534785pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16534785pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16534785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16534785pubmed:statusMEDLINElld:pubmed
pubmed-article:16534785pubmed:monthAprlld:pubmed
pubmed-article:16534785pubmed:issn0008-543Xlld:pubmed
pubmed-article:16534785pubmed:authorpubmed-author:RolstonKennet...lld:pubmed
pubmed-article:16534785pubmed:authorpubmed-author:SafdarAmarAlld:pubmed
pubmed-article:16534785pubmed:copyrightInfo2006 American Cancer Societylld:pubmed
pubmed-article:16534785pubmed:issnTypePrintlld:pubmed
pubmed-article:16534785pubmed:day15lld:pubmed
pubmed-article:16534785pubmed:volume106lld:pubmed
pubmed-article:16534785pubmed:ownerNLMlld:pubmed
pubmed-article:16534785pubmed:authorsCompleteYlld:pubmed
pubmed-article:16534785pubmed:pagination1815-20lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:meshHeadingpubmed-meshheading:16534785...lld:pubmed
pubmed-article:16534785pubmed:year2006lld:pubmed
pubmed-article:16534785pubmed:articleTitleVancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer.lld:pubmed
pubmed-article:16534785pubmed:affiliationDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. asafdar@mdanderson.orglld:pubmed
pubmed-article:16534785pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16534785pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16534785lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16534785lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16534785lld:pubmed